Navigation Links
Kendle Announces Third Quarter 2009 Results
Date:11/4/2009

previously discussed insurance recovery and related item had a net positive impact on the year-to-date operating margin of 1.0 percent of net revenues.

Net income was $12.9 million for the first nine months of 2009 compared with net income of $19.8 million for the same period last year. Net income per share on a diluted basis for the nine months ended Sept. 30, 2009 was $0.86 per share compared with $1.32 per diluted share for the first nine months of 2008. On a pro forma basis, net income per diluted share for the first nine months of 2009 was $1.61 compared with $1.63 for 2008.

Cash flow from operations for the first nine months of 2009 was strong at $50.0 million compared with $3.5 million for the same period of the prior year. Capital expenditures for the nine month period totaled $14.1 million versus $18.1 million for the same period last year.

Third Quarter 2009 Conference Call and Webcast Details

Kendle will host its Third Quarter 2009 conference call on Nov. 5, 2009, at 8:30 a.m. Eastern Time. The call will be broadcast live over the Internet and can be accessed at www.kendle.com. A replay of the Webcast will be available at www.kendle.com shortly after the call for on-demand replay through 5 p.m. Eastern Time on Dec. 4, 2009.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-
'/>"/>

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Kendle Announces Details Regarding Second Quarter 2009 Earnings Conference Call and Webcast
2. Kendle to Share Insights at Drug Information Association 45th Annual Meeting
3. Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
4. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
5. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
6. Kendle Revises Full Year 2008 Guidance
7. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
8. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
9. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
10. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
11. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Today, UWDress.com, the famous women’s dress supplier, has presented its ... site-wide wedding gown promotion. , For those who ... unexpected way, the collection should be a great choice. The ... and they are available with custom service. , Now, all ... up to 75% off; most of them come in hot ...
(Date:12/24/2014)... 2014 Mike Billings , PT, ... Derek Fenwick, PT, MBA, GCS, Director of Professional ... from the passing of the Improving Medicare Post-Acute ... this taping of the Infinicast, the two leaders discuss ... Social Security Act to standardize post-acute assessment data for ...
(Date:12/24/2014)... -- The holidays can be a challenge for people who ... and drinks. "This is the season in which many ... Dr. David Dodick, chair of the American Migraine Foundation, said ... to think through food and beverage choices, to help reduce ... professor of neurology at the Mayo Clinic in Scottsdale, Ariz. ...
(Date:12/24/2014)... Dec. 24, 2014 (HealthDay News) -- Adults who ... risk of migraine headaches, suggests a study published ... . "Childhood maltreatment can have long-lasting effects, ... in adulthood," study author Dawn Buse, director of ... York City, said in a journal news release. ...
(Date:12/24/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- A lab ... Prevention may have been exposed to the Ebola virus ... And up to a dozen other lab workers ... late Wednesday afternoon. The possible exposure occurred Monday ... a sample of the potentially lethal virus to another ...
Breaking Medicine News(10 mins):Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Expert Offers Tips for Preventing Holiday Migraines 2Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:CDC Monitors Lab Worker for Possible Ebola Exposure 2
... for Helicobacter pylori as the decay-accelerating factor (DAF), a ... , Blocking this interaction could lead to new drugs ... gastric cancer. The research appears as the ‘Paper of ... Journal of Biological Chemistry, an American Society for Biochemistry ...
... In a new clinical development partnership being launched ... arm, Cancer Research Technology (CRT) plans to take ... for not showing enough commercial promise following their ... new treatments from anti-cancer drugs that have been ...
... by the defence attorneys of the AIIMS hospital, has sought ... where a boy, suffering from cancer, got inflicted with AIDS ... ,The victim, who was nine years old at the ... for treatment of cancer, supposedly has contracted HIV due to ...
... drug Zoloft (sertraline) may avoid in preventing recurring of ... interval between the depressive episodes. ,One in every ... the study, reports foodconsumer.org. ,Researchers studied 152 ... recovered from depression during treatment with Zoloft -- 79 ...
... recent conducted at University of Michigan Health Systems in ... greater expectations of doom from their screening //mammography for ... not these expectations were unusually high or unrealistic. ... an outpatient clinic for screening mammography. The participants were ...
... Computer keyboards used in hospitals are a reservoir for ... to be disinfected every day, a new study warns.// ... various locations inside University of North Carolina hospitals and ... two types of bacteria, reports the science portal HealthCentral. ...
Cached Medicine News:Health News:Receptor for H.pylori Identified in Stomach 2Health News:Cancer Research UK Offers New Hope To Cancer Patients 2Health News:A Boy Undergoing Treatment For Cancer Gets AIDS At AIIMS 2Health News:Most Women Have Unrealistic Expectations From Screening Mammography 2Health News:Computer Keyboards In Hospitals Could Spread Infection To Patients 2
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
(Date:12/24/2014)... and FARMINGTON, Conn. ... Inc. (NYSE MKT: PTN), a biopharmaceutical company developing ... diseases with significant unmet medical need and commercial ... a private placement of 2,050,000 shares of its ... 24,949,325 shares of its common stock.  Funds under ...
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... Innovations, LLC, a leading developer and marketer of high ... of their new European office in Enschede, the Netherlands ... management team and new European staff, local Enschede dignitaries ... of Economic Affairs in The Netherlands and Mr. Jan ...
... 31, 2011 Omni Bio Pharmaceutical, Inc. (OTC BB: OMBP), ... To the Shareholders of Omni Bio Pharmaceutical, Inc.: ... first month as the Chief Executive Officer of Omni Bio ... a close, this is an appropriate juncture to update our ...
Cached Medicine Technology:Freedom Innovations Opens New European Headquarters 2Omni Bio Pharmaceutical, Inc's. CEO Issues Letter to Shareholders 2Omni Bio Pharmaceutical, Inc's. CEO Issues Letter to Shareholders 3Omni Bio Pharmaceutical, Inc's. CEO Issues Letter to Shareholders 4Omni Bio Pharmaceutical, Inc's. CEO Issues Letter to Shareholders 5Omni Bio Pharmaceutical, Inc's. CEO Issues Letter to Shareholders 6
... a convenient, reusable, patient-friendly and effective ... orthopedic conditions/instabilities. These products are designed ... lateral to medial influence of cutaneous ... and soft tissue structures. Maximum benefit ...
... state-of-the-art laser scanning technology for an anatomically-contoured, ... lean, athletic legs. Offering the same ... Flex Sport's "second skin" fit conforms to ... no other off-the-shelf knee brace., ,Indications: ...
... Drytex Adjustable Patella Donut is a ... nylon core and polyester Lycra Fabric ... trimable full-circumference donut provides for patellar ... neoprene based allergies or irritations. Click ...
... of the Custom Montana2 alleviates the ... three-point load across the knee joint, ... area. The Diagonal Loading Strap gives ... the load to accommodate their daily ...
Medicine Products: